PART I Item 1. Busin ess. Overview We are a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System ...
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-24 | 2025-12-31 | 0001193125-26-067238 | EDGAR | 93K words |
| 2025-02-25 | 2024-12-31 | 0000950170-25-026773 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-04 | 2025-09-30 | 0001193125-25-264882 | EDGAR | 65K words |
| 2025-08-05 | 2025-06-30 | 0000950170-25-103142 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000950170-25-067097 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125409 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-24 | 0001193125-26-067136 | EDGAR | 3K words |
| 2026-01-05 | 0001193125-26-001800 | EDGAR | — |
| 2026-01-02 | 0001193125-26-000994 | EDGAR | — |
| 2025-12-12 | 0001193125-25-317295 | EDGAR | — |
| 2025-12-09 | 0001193125-25-312035 | EDGAR | — |
| 2025-11-24 | 0001193125-25-292140 | EDGAR | — |
| 2025-11-04 | 0001193125-25-264699 | EDGAR | — |
| 2025-09-24 | 0001193125-25-214813 | EDGAR | — |
| 2025-09-22 | 0001193125-25-210195 | EDGAR | — |
| 2025-08-05 | 0000950170-25-103052 | EDGAR | — |
32 total filings indexed. 16 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001861107 |
| Ticker | CBLL |
| Exchange | Nasdaq |
| SIC | 3845: Electromedical & Electrotherapeutic Apparatus |
| Incorporated | DE |
| Website | https://www.ceribell.com |
| Listed | 2024-10-11 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report